Abstract
Hydroxychloroquine has gained popularity as a potential preventative and treatment of COVID-19 pneumonia due to its in vitro activity against the virus. These three cases of COVID-19 pneumonia of varying severities occurred in the setting of chronic hydroxychloroquine use. These cases argue against the use of hydroxychloroquine as a preventative or therapeutic option for COVID-19 pneumonia.
Cite
CITATION STYLE
Rahman, A. K., Purdy, A. G., & Ender, P. T. (2020). COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia. Case Reports in Infectious Diseases, 2020, 1–4. https://doi.org/10.1155/2020/8822753
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.